Complement Control Cells

Immunohematology - red cell reagents/enzyme-treated red cells · class III · Until 18/01/2031

Registration no.
10154450205
Process no.
25351708949202054
Status
Until 18/01/2031
Device type
Immunohematology - red cell reagents/enzyme-treated red cells (IMUNOHEMATOLOGIA - REAGENTES DE HEMÁCIAS/DE HEMÁCIAS TRATADAS COM ENZIMAS)
Risk class
III
Registration holder
FRESENIUS HEMOCARE BRASIL LTDA. CNPJ 49.601.107/0001-84 · 299 registrations
Manufacturer
IMMUCOR INC · United States
Published
18/01/2021
Valid until
18/01/2031
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other immunohematology - red cell reagents/enzyme-treated red cells registrations (33 in total, see all)

ProductClass HolderPublishedStatus
Screen-Cyte Dia 3%
80134860297
III GRIFOLS BRASIL LTDA 23/10/2023 Until 23/10/2033
Sero-Cyte 3%
80134860299
III GRIFOLS BRASIL LTDA 23/10/2023 Until 23/10/2033
Data-Cyte Plus 3%
80134860300
III GRIFOLS BRASIL LTDA 23/10/2023 Until 23/10/2033
Sero-Cyte Pool Diª 0.8%
80134860291
III GRIFOLS BRASIL LTDA 26/06/2023 Until 26/06/2033
Data-Cyte Extend 0.8%
80134860284
III GRIFOLS BRASIL LTDA 08/08/2022 Until 08/08/2032
Diego(a)-Cyte 0.8%
80134860280
III GRIFOLS BRASIL LTDA 06/09/2021 Until 06/09/2031
Data-Cyte Plus P 0.8%
80134860279
III GRIFOLS BRASIL LTDA 30/08/2021 Until 30/08/2031
Screen-Cyte P 0.8%
80134860274
III GRIFOLS BRASIL LTDA 22/03/2021 Until 22/03/2031